Quantcast

Pharma news

Mundipharma Announces the Licence Extension Submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to the European Medicines Agency

The licence extension submission for Invokana® (canagliflozin) and Vokanamet® (canagliflozin and metformin) to treat type 2 diabetes mellitus (T2DM) patients

Posted in news | Leave a comment

Fitch Ratings Upgrades Bio-Rad to BBB, ‘Outlook Stable,’ Reflecting Continued Improvement in the Company’s Operating Performance

HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,

Posted in news | Leave a comment

IQVIA to Participate in Baird 2019 Global Healthcare Conference on September 4, 2019

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ari Bousbib, chairman and chief

Posted in news | Leave a comment

Bioasis Announces Registration and Grant Notice of Patent Application in China Relating to xB3 Platform Technology for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier

GUILFORD, Conn.–(BUSINESS WIRE)–BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3

Posted in news | Leave a comment

Abacus Health Products Announces Revised Release Date for 2019 Second Quarter Financial Results, Conference Call and Webcast

WOONSOCKET, R.I.–(BUSINESS WIRE)–$ABAHF #OTCQB–Abacus Health Products, Inc. (CSE: ABCS, OTCQX: ABAHF) (“Abacus” or the “Company”) will release its 2019 second

Posted in news | Leave a comment

AmeriHealth Caritas New Hampshire Contracts With SolutionHealth to Serve New Hampshire Medicaid Enrollees

MANCHESTER, N.H.–(BUSINESS WIRE)–#AmeriHealthCaritas—AmeriHealth Caritas New Hampshire and SolutionHealth announced they have signed a contract that will allow AmeriHealth Caritas New

Posted in news | Leave a comment

U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer

XTANDI Supplemental New Drug Application (sNDA) Seeks to Add an Indication for Men with Prostate Cancer that Has Spread but

Posted in news | Leave a comment

Glass House Group, One of the Most Quickly Expanding, Privately Held, Vertically Integrated Cannabis and Hemp Companies, Appoints Board Members

Entrepreneur/Private Investor Steve Ruchefsky and Co-Founder of Magu Capital Jocelyn Rosenwald to Leverage Years of Diverse Experience across the Financial,

Posted in news | Leave a comment

Global Solid Tumor Cancer Treatment Market Report, 2017-2019 & 2027: Industry Size & Share, Application Analysis, Growth Trends, Key Players, and Competitive Strategies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Solid Tumor Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive

Posted in news | Leave a comment

Track & Trace Solutions Market Set to Exceed $6.8 Billion by 2026 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Track And Trace Solutions Market Size, Share & Trends Analysis Report By Product, By Technology (Barcodes, RFID), By

Posted in news | Leave a comment

Eisai, Biogen kick-off phase 3 testing early Alzheimer’s disease antibody, amid dropping aducanunab trial. Eisai’s US company presents AD pipeline

Eisai Co said Friday thata global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer’s disease has been initiated.

Posted in Approval, Asia, Europe, North America, Regions | Tagged , , | Leave a comment

ProMIS offeri potential significant advantage over aducanumab, learns from mistakes

ProMIS Neurosciencesissued a pres release Friday, raising urgency to selectively target the toxic oligomer with exacting precision as part of the global effort to develop disease-modifying therapies for Alzheimer’s disease (AD), upon Biogen’s and Eisai’s dropping two alte-stage clinical trials of aducanumab.

Posted in Approval, North America | Tagged , , , , | Leave a comment

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma

@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.

Posted in Approval, Asia, Europe, news | Tagged , , | Leave a comment

Gelesis Announces Three Presentations at Annual Endocrine Society Meeting

BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI)

Posted in Approval, news, North America | Tagged | Leave a comment

CB Therapeutics Secures new Research and Production Facility

SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is an innovative biotechnology company focusing on research and production of cannabinoids. The company utilizes its

Posted in Approval, news | Tagged | Leave a comment

Vaxart Announces Closing of Registered Direct Offering of Common Stock

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather

Posted in Approval, news, North America | Tagged | Leave a comment

First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research Institute

STERLING, Kan.–(BUSINESS WIRE)–Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Life Sciences Limited, announced today that the first patient

Posted in Approval, news, North America, Regions | Tagged , , , , , | Leave a comment

Transgene: A Positive 2018, Moving Ahead with a Strong Portfolio

2018 Full-year results and business update Clinical trials set to announce key data in 2019 Invir.IO™ platform designed to deliver

Posted in Approval, news | Tagged | Leave a comment

Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai

SHANGHAI–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Shanghai?src=hash" target="_blank"gt;#Shanghailt;/agt;–To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center

Posted in Approval, Asia, news, Regions | Tagged | Leave a comment

MichBio Announces 7th Annual “Michigan Biosciences Day at the Capitol,” Seeks Participants

ANN ARBOR, Mich. & LANSING, Mich.–(BUSINESS WIRE)–Michigan’s premier biosciences industry trade organization, MichBio, presents its annual Michigan Biosciences Day at

Posted in Approval, news | Tagged | Leave a comment